Physician profile
Mary E Devillier
NPI 1093290975
$826.04
in general payments reported to CMS, 2019-2025
11 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.19 · 2023: $179 · 2024: $323 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $511.44 | 2022-2025 | Relistor |
| Nevro Corp. | $53.06 | 2023-2024 | Senza |
| Saluda Medical Americas, INC. | $42.08 | 2024 | Evoke |
| Relievant Medsystems, INC. | $39.55 | 2023 | Intracept |
| Vertos Medical, INC. | $35.64 | 2023 | Mild Device Kit |
| Curonix LLC | $32.32 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $31.45 | 2024-2025 | |
| Medtronic, INC. | $30.30 | 2022-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $22.45 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $15.02 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Devillier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.